How Did HIV/AIDS Prepare Us for COVID-19?
Forty years after a 1981 report hinted at the coming HIV/AIDS pandemic, we look at how the response to global public health threats has changed.
The Sex, Lies, and Videotape of Cancer Cells
Cells we were taught to ignore have been caught on tape doing the unthinkable.
The Future of Chronic Pain
For the millions of people suffering with daily physical pain, nerve stimulation and gene editing offer new hope beyond addictive opioids.
The Case for More Doping in the Olympics
Some tech and drug enhancements are banned as unfair, but ironically they could end up leveling the playing field.
AI Breathes New Life into Old Drugs
Deep learning uncovers the potential of existing medications to target different diseases.
Lithium: The Next Trend in Microdosing?
Low levels of the naturally occurring, soft shiny metal could reduce violence and enhance moods for all.
Inside the Movement to Decolonize Psychedelic Pharma
As Western medicine brings psychedelics into mainstream use, a growing movement is innovating new business models grounded in reciprocity and inclusion.
There Might Be a Better Time to Pop That Pill
Syncing cures with circadian rhythms is an idea whose moment has finally come.
Take These Drugs to Get to Mars
Space brain and other cosmic problems demand new kinds of pharmaceutical protection.
How a DNA Test Can Help You Deal with Depression
Gene tests for antidepressants are going mainstream — and getting more confusing. Here’s a guide.
Your Next Rx: Less Testing, Fewer Drugs — and Better Health
Soon, precision medicine could help you avoid expensive, risky procedures that you may not need.
The Latest Biotech Growth Market Might be Crap
There’s gold in your gut—and startups are mining it with microbiome science. The biggest hurdle? Stool doesn’t scale.
This Scientist-Turned-VC Wants to Extend Life
Since he was a child, James Peyer has been obsessed with stopping aging. Now he has a fund — and a plan.